Rayvio_News_Filter
$MDCX 🤝
Medicus Pharma Ltd. announced that its wholly-owned subsidiary SkinJect entered a non-binding letter of intent with an undisclosed SPAC for a proposed business combination valuing SkinJect at approximately $135 million, with concurrent financing to support the SKNJCT-005 NDA-enabling study.
Curated for market relevance
1
